MedTrace Logo

Alcohol Screening in an Ethnically Diverse Sample of Adolescents in Primary Care

NCT01797835 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 294

Last updated 2019-07-17

Study results available
· View outcomes & findings →

Summary

Screening youth in the primary care setting is one way to identify adolescents who may be at-risk for future alcohol problems. The current study tests the new NIAAA screening guide questions, which ask about friend and adolescent drinking, to see how well these questions work to predict subsequent alcohol use, problems, and involvement in other risk behaviors, such as sexual risk-taking and delinquency. In addition, the investigators plan to provide a brief motivational intervention for some at-risk teens and see whether alcohol use differs for those teens who receive the intervention and those teens who receive enhanced usual care. The results of this study have the potential to significantly impact the standard of care for identifying and intervening with at- risk youth in primary care settings.

Conditions

  • Alcohol Use
  • Drug Use

Interventions

BEHAVIORAL

CHAT brief MI intervention

CHAT is one 15-20 minute session delivered in a single PC visit and utilizes motivational interviewing with youth to target alcohol and drug use in primary care.

BEHAVIORAL

usual care

Youth receive a brochure with information on AOD use.

Sponsors & Collaborators

  • Valley Community Clinic

    collaborator UNKNOWN

  • University of Pittsburgh

    collaborator OTHER

  • RAND

    lead OTHER

Principal Investigators

  • Elizabeth J D'Amico, PhD · RAND

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2015-11-30
Completion
2018-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01797835 on ClinicalTrials.gov